Tonix Pharmaceuticals Holding Corp.
Organization details
- Legal name
- Tonix Pharmaceuticals Holding Corp.
- Former names
- Tamandare Explorations INC.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Berkeley Heights
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TNXP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001430306
- EIN
- 26-1434750
Board of directors
-
Adeoye Y. Olukotun · DirectorSince 2023
-
Carolyn E. Taylor · DirectorSince 2023
-
David L. Grange · DirectorSince 2023
-
James Randolph Hunter Jr. · DirectorSince 2025
-
James Treco · DirectorSince 2023
-
Margaret Smith Bell · DirectorSince 2023
-
Richard H. Bagger · DirectorSince 2023
-
Richard Newcomb Stillwell · DirectorSince 2023
-
Seth Lederman · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
45.2%
-
48.9%
-
52.8%
-
52.9%
-
53.1%
-
53.6%
-
53.8%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Arrowhead Pharmaceuticals Inc. Same sectorvia Adeoye Y. Olukotun
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $479,033
- 8 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 11, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $4.06 | $20,275 |
| Aug 27, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +2,000 | $13.79 | $27,580 |
| Aug 20, 2026 | Richard H. Bagger Director | Open-market purchase | +1,000 | $12.60 | $12,600 |
| Jun 30, 2026 | SAENGER BRADLEY Officer (Chief Financial Officer) | Other | +1,453 | $10.91 | $15,852 |
| Jun 12, 2026 | Carolyn E. Taylor Director | Open-market purchase | +1,415 | $10.55 | $14,928 |
| Jun 9, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $11.79 | $58,950 |
| Jun 8, 2026 | Richard Newcomb Stillwell Director | Open-market purchase | +5,000 | $11.65 | $58,250 |
| Mar 31, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $12.62 | $63,100 |
| Mar 18, 2026 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +15,000 | $14.89 | $223,350 |
| Dec 31, 2025 | SAENGER BRADLEY Officer (Chief Financial Officer), 10% owner | Grant or award | +701 | $13.42 | $9,407 |
| Aug 21, 2025 | Carolyn E. Taylor Director | Open-market purchase | +418 | $36.03 | $15,061 |
| Aug 20, 2025 | James Treco Director | Open-market purchase | +250 | $36.00 | $9,000 |
| May 15, 2025 | Seth Lederman Director, Officer (Chief Executive Officer) | Open-market purchase | +4,000 | $21.55 | $86,200 |
| Feb 5, 2025 | Margaret Smith Bell Director | Other | −1 | $0.15 | $0 |
| Feb 5, 2025 | James Treco Director | Other | −0 | $0.30 | $0 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tonix Pharmaceuticals Holding Corp.
Who is the CEO of Tonix Pharmaceuticals Holding Corp.?
Seth Lederman is Tonix Pharmaceuticals Holding Corp.'s Chief Executive Officer.
How many directors are on Tonix Pharmaceuticals Holding Corp.'s board?
Tonix Pharmaceuticals Holding Corp.'s board has 9 directors: Adeoye Y. Olukotun, Carolyn E. Taylor, David L. Grange, James Randolph Hunter Jr., James Treco, Margaret Smith Bell, Richard H. Bagger, Richard Newcomb Stillwell and Seth Lederman.
Are Tonix Pharmaceuticals Holding Corp. insiders buying or selling shares?
Over the last 12 months, Tonix Pharmaceuticals Holding Corp. insiders bought $479,033 of shares in 8 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tonix-pharmaceuticals-holding-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.